Overview
My laboratory is interested mechanisms of kidney injury in disease states and the role of the kidney in regulation of blood pressure. Our research addresses issues that are relevant to disorders such as hypertension, diabetic nephropathy, transplant rejection, and autoimmune diseases. We have been particularly interested in two hormone systems that impact these processes: (1) the renin-angiotensin system and (2) lipid mediators derived from cyco-oxygenase metabolism of arachidonic acid. Our studies have taken advantage of available technologies for producing genetic alterations in mice to study the physiology of these systems. As one example, we generated and characterized lines of mice lacking the major physiological receptors for angiotensin II in the mouse. These studies have provided novel information regarding the role of these receptors in blood pressure homeostasis, in promoting kidney injury in disease states, and in the regulation of inflammation. A major objective of our work is to identify new approaches to treatment and disease prevention. To this end, we are using molecular genetic technology to develop and refine mouse models of human diseases such as diabetic nephropathy, kidney transplant rejection, and hypertension.
Current Duke Appointments & Affiliations
James R. Clapp Distinguished Professor of Medicine, in the School of Medicine
·
2002 - Present
Medicine, Nephrology,
Medicine
Professor of Medicine
·
1999 - Present
Medicine, Nephrology,
Medicine
Professor in Cell Biology
·
2005 - Present
Cell Biology,
Basic Science Departments
Professor in Integrative Immunobiology
·
2006 - Present
Integrative Immunobiology,
Basic Science Departments
Recent Scholarly Works
Proximal tubule ACE2 mediates early responses to hypertension by regulating intrarenal RAS and sodium homeostasis.
Journal article JCI Insight · September 22, 2026 ACE2 is a membrane-bound monocarboxypeptidase strongly expressed in the renal proximal tubule (PT) with high affinity to degrade the vasopressor angiotensin II (AngII). We employed a mouse model of PT-specific ACE2 deletion (PT ACE2-KO) to demonstrate that ... Full text Link to item CitePrecision Approaches to Kidney Disease in Asia: Perspectives from Singapore.
Journal article J Am Soc Nephrol · July 22, 2026 Full text Link to item CiteBeyond lipids: fenofibrate in diabetic retinopathy and nephropathy.
Journal article Trends Pharmacol Sci · March 2026 Diabetic retinopathy (DR) and nephropathy (DN) are leading microvascular complications of diabetes, yet current therapies remain inadequate. Fenofibrate, a peroxisome proliferator-activated receptor (PPAR)-α agonist approved for dyslipidemia, has gained at ... Full text Link to item CiteRecent Grants
2/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Center for Advancing Translational Sciences · 2025 - 2030Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023View All Grants
Education
Ohio State University ·
1980
M.D.